Trial Profile
A study investigating the effect of vinflunine in metastatic transitional cell carcinoma of the urothelial tract patients who failed one cisplatin-based systemic therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jun 2019
Price :
$35
*
At a glance
- Drugs Vinflunine (Primary)
- Indications Carcinoma; Urogenital cancer
- Focus Adverse reactions; Therapeutic Use
- 04 Jun 2019 Results assessing association of immune gene expression profiling with vinflunine clinical benefit presented at the 55th Annual Meeting of the American Society of Clinical Oncology
- 19 Dec 2015 New trial record